Showing results (11-20 of 1,434) with videos related to
Sort By:
Pageof 144
Bone Marrow Transplantation|February 1, 1996
Outcome of autologous rescue after failed engraftment of allogeneic marrowJ Mehta, R Powles, S Singhal, et al.Leukemia & Lymphoma|January 1, 1997
Long-term safety of GM-CSF (molgramostim) administration after allogeneic bone marrow transplantation for hematologic malignancies: five-year follow-up of a double-blind randomized placebo-controlled studyS Singhal, R Powles, J Treleaven, et al.Bone Marrow Transplantation|August 1, 1996
Factors affecting engraftment and hematopoietic recovery after unpurged autografting in acute leukemiaJ Mehta, R Powles, C Horton, et al.Bone Marrow Transplantation|July 1, 1997
Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patientsJ Mehta, R Powles, S Kulkarni, et al.Leukemia & Lymphoma|February 1, 1997
Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignanciesS Singhal, R Powles, J Treleaven, et al.Acta Haematologica|January 1, 1992
A randomized placebo-controlled double-blind study of danazol in hemophilia AJ Mehta, S Singhal, M V Kamath, et al.The Journal of the Association of Physicians of India|June 1, 1993
Autoantibodies in thalassaemia major: relationship with oral iron chelator L1J Mehta, A Chablani, R Reporter, et al.Leukemia Research|November 1, 1996
Failure of cyclosporine to induce graft-vs-host disease or graft-vs-leukemia after syngeneic bone marrow transplantation in miceS Singhal, U Vourka-Karussis, J Mehta, et al.Bone Marrow Transplantation|November 7, 2002
Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myelomaS Singhal, R Powles, B Sirohi, et al.Leukemia & Lymphoma|June 1, 1997
Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantationJ Mehta, R Powles, S Singhal, et al.Pageof 144